Scout | Alzheimer's Clinical Trials Consortium (ACTC) Clinical Trials (R01 Clinical Trial Required)

This opportunity is no longer accepting applications.

grant

Alzheimer's Clinical Trials Consortium (ACTC) Clinical Trials (R01 Clinical Trial Required)

This grant opportunity seeks applications to conduct clinical trials (Phase Ib to III) on potential treatments, including both drug-based and non-drug approaches, aimed at preventing, delaying, or alleviating symptoms of Alzheimer's disease and other dementias. The trials will utilize the Alzheimer's disease Clinical Trials Consortium (ACTC) for coordination and management.

Source

Agency: National Institutes of Health

Program: SBIR

Dates

Open for Submission: July 1, 2024

Submission Deadline: October 17, 2024

Application Window Closes: October 17, 2024

Opportunity Released: July 1, 2024

Keywords

Alzheimer's disease

clinical trials

pharmacological interventions

non-pharmacological interventions

age-related dementias

trial coordination

trial management

ACTC

Phase Ib to III trials

Alzheimer's prevention.

Supporting Links

Documents

Similar Opportunities

Unlock similar opportunities

Get the full picture on this opportunity

Create a free Scout account to unlock everything you need to decide fast and win the grant.

Instant Fit Analysis

Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
Deep agency & funder detail

Program context, sub-agency structure, and a full eligibility breakdown.
Source links & full documents

Jump straight to the solicitation and download every attachment.
Similar opportunities

Discover related funding matched to your work.

Get a Demo Sign Up

Already have an account? Sign In

Trusted by 500+ Happy Customers